Breaking News Bar

Business News and Information

The Daily Herald Market Index
Markets
Stocks
Funds
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Recent Quotes
My Watchlist
Indicators
Local Stocks
Calithera Biosci Com (NQ: CALA)
5.000 USD  UNCHANGED
Official Closing Price  /  Updated: 4:40 PM EDT, Sep 25, 2018  /  Add to My Watchlist      
View: Quote News Research
Price and Volume
Detailed Quote
Chart for (: )
 
Intraday
1 Week
1 Month
3 Month
1 Year
  
Compare to:
Volume 250,300
Open 5.050
Bid (Size) 4.050 (5)
Ask (Size) 5.500 (2)
Prev. Close 5.000
Today's Range 4.950 - 5.200
52wk Range 4.050 - 18.35
Shares Outstanding 35,844,686
Dividend Yield N/A
Performance
YTD
-43.82%
-43.82%
1 Month
+1.01%
+1.01%
3 Month
-2.91%
-2.91%
6 Month
-25.93%
-25.93%
1 Year
-68.65%
-68.65%
Top News
More News
Calithera Biosciences to Present at the 2018 Cantor Fitzgerald Global Healthcare Conference and the Leerink Partners Rare Disease & Oncology Roundtable
Calithera Biosciences, Inc. (Nasdaq: CALA), a clinical-stage pharmaceutical company focused on discovering and developing novel small molecule drugs directed against tumor metabolism and tumor... Read More
from GlobeNewswire News Releases
Calithera Biosciences to Participate in the Citi 13th Annual Biotech Conference and the Wells Fargo Healthcare Conference
Calithera Biosciences, Inc. (Nasdaq: CALA), a clinical stage biotechnology company focused on the development of novel cancer therapeutics, today announced its participation at two upcoming healthcare... Read More
from GlobeNewswire News Releases
More News
Read More
Recent Analysis Shows Ellie Mae, Organovo, Calithera Biosciences, Whirlpool, Marathon Oil, and Infinera Market Influences — Renewed Outlook, Key Drivers of Growth
from GlobeNewswire News Releases
Calithera Biosciences Reports Second Quarter 2018 Financial Results and Recent Highlights
from GlobeNewswire News Releases
Calithera Biosciences to Report Second Quarter 2018 Financial Results on Tuesday, August 7, 2018
from GlobeNewswire News Releases
Calithera to Present at the Jefferies and JMP Securities Healthcare Conferences in June
from GlobeNewswire News Releases
Results from Phase 1 Study of CB-839 in Combination with Capecitabine in Advanced Solid Tumors to be Presented at the 2018 American Society of Clinical Oncology (ASCO)
from GlobeNewswire News Releases
Research Report Identifies Monster Beverage, Infinera, Zynga, Calithera Biosciences, Marathon Oil, and National Instruments with Renewed Outlook — Fundamental Analysis, Calculating Forward Movement
from GlobeNewswire News Releases
Analysts See 22% Upside For IBB
category ETFs
from ETF Channel
Short Interest In Calithera Biosciences Moves 32% Lower
category Stocks
from Market News Video
Calithera Biosciences Enters Oversold Territory (CALA)
category Stocks
from Market News Video
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Six Financial & Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
bottom clear
Search DailyHerald.com for articles
More ways to search Daily Herald
Obituaries
Search DailyHerald.com obituaries. » Daily Herald newspaper archive
Find archived newspaper articles back to 1901. »
Digital Subscriptions
Activate Subscriber Access Purchase a Digital Subscription
Home Delivery
Start a New Subscription Manage Account